Lukas Enembe Dipastikan Terus Sidang Hingga Vonis Meski Sakit Kidney Kronis
JAKARTA - The Corruption Eradication Commission (KPK) ensures that the inactive Papua Governor Lukas Enembe will be tried even though he has health problems. He will be held accountable for the alleged bribery and gratification that ensnared him. "Yes, of course, because it is an accountability in a process of handling corruption crimes that must be completed, there is an end," Acting Deputy for Enforcement and Execution of the KPK Asep Guntur told reporters quoted on Friday, July 28. Asep also said the trial will continue to be held for the sake of legal certainty. However, Lukas was asked not to worry because the trial would be held while he was in good health. "We are also not carelessly, for example presenting Mr. LE at trial, yes, we will definitely refer to the results or medical opinions of the doctors," he stressed. Previously, Lukas Enembe's lawyer said his client's condition was unhealthy. They held data from the Army Central Hospital (RSPAD) Gatot Soebroto who said Lukas was suffering from chronic kidney disease. The lukas is said to have undergone kidney therapy to try fun. He was also required to undergo a diet and reduce activities. For information, Lukas was charged with receiving bribes and total gratuities of Rp46.8 billion. The act was contrary to his obligations as state administrators.
SEE ALSO:
In detail, Rp10.4 billion came from the owners of PT Melonesia Mulia, Piton Enumbi and Rp35.4 billion received from the Director of PT Tabi Anugerah Pharmindo, Rijatono Lakka. The money was given so that Lukas won the two companies in the project for the procurement of goods and services within the Papua Provincial Government for the 2013-2022 Fiscal Year. The lukas was charged with committing the act together with a number of parties. They are the Head of the Papua Province Public Housing Service (PU) for the 2013-2017 period Mikael Kambuaya and the Head of the Papua Province Public Works and Spatial Planning (PUPR) Office for the 2018-2021 period.